Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
BRUSSELS, March 10, 2016 - UPS (NYSE: UPS) announced the launch of UPS Temperature True® Cryo in Europe, providing healthcare customers access to end-to-end product protection and capability to ship parcels in a cryogenic environment. The service includes real-time tracking and intervention, which, when combined with UPS’s risk mitigation solutions and global network of control towers, will provide complete visibility for shipments at every stage of the supply chain journey.
This solution uses Cryoport's leading-edge cryogenic containers, which allow UPS customers to use liquid nitrogen stored in dry vapour form to keep products frozen at -150°C for 10 days while in transit or storage. When meeting minimum volume levels, shipments can also be paired with UPS Proactive Response® Secure, a financial protection service that provides coverage for these time- and temperature-sensitive shipments.
"When products requiring cryopreservation are on the move, customers want peace of mind that their shipments are safeguarded, so bringing this solution to the Europe market was a logical next step as we continue to expand our best-in-class logistics services globally for the healthcare and life science industries,” said Jan Denecker, Director of Healthcare Marketing & Strategy, UPS Europe. “UPS Temperature True Cryo combines innovative packaging, 24/7 monitoring and intervention capabilities for the most critical time- and temperature-sensitive specimens across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health.”
The most recent UPS Pain in the Chain survey, a global study that measures the top pain points in healthcare supply chain management, shows that product security, damage and spoilage continue to be top of mind for healthcare executives. The new UPS Temperature True Cryo service along with UPS Proactive Response Secure, will add tremendous value to researchers, lab technicians and healthcare practitioners shipping often-invaluable specimens and samples requiring cryopreservation.
The UPS Temperature True® portfolio offers broad storage, transportation and packaging services for products ranging from cryogenic to ambient, specifically tailored for companies in the pharmaceutical, biotech and medical device industries. These services are complemented by extensive regulatory expertise and a global network of 51 UPS healthcare-dedicated facilities.
